Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-015792
Filing Date
2019-08-14
Accepted
2019-08-14 16:06:20
Documents
65
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0619_chinapharmaholdings.htm 10-Q 424681
2 ENGLISH TRANSLATION OF THE LOAN AGREEMENT BETWEEN THE COMPANY AND ZHILIN LI DATE f10q0619ex10-1_chinapharma.htm EX-10.1 8504
3 CERTIFICATION f10q0619ex31-1_chinapharma.htm EX-31.1 10436
4 CERTIFICATION f10q0619ex31-2_chinapharma.htm EX-31.2 10600
5 CERTIFICATION f10q0619ex32-1_chinapharma.htm EX-32.1 5021
  Complete submission text file 0001213900-19-015792.txt   2585239

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cphi-20190630.xml EX-101.INS 345452
7 XBRL SCHEMA FILE cphi-20190630.xsd EX-101.SCH 36490
8 XBRL CALCULATION FILE cphi-20190630_cal.xml EX-101.CAL 61135
9 XBRL DEFINITION FILE cphi-20190630_def.xml EX-101.DEF 85478
10 XBRL LABEL FILE cphi-20190630_lab.xml EX-101.LAB 246061
11 XBRL PRESENTATION FILE cphi-20190630_pre.xml EX-101.PRE 190036
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 191026279
SIC: 2834 Pharmaceutical Preparations